Spero Therapeutics (SPRO) Price to Sales (2017 - 2026)
Spero Therapeutics' (SPRO) Price to Sales stood at 2.73 in Q2 2026, down 18.5% from 3.35 a year earlier but up 23.5% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Price to Sales (2017 - 2026) Analysis & Trends
For FY2025, Spero Therapeutics' Price to Sales came in at 1.97, up 67.9% from FY2024.
- Across earlier years, Price to Sales came in at 1.17 in FY2024 (+56.1%), 0.75 in FY2023 (-38.2%), 1.22 in FY2022 (-95.7%) and 28.41 in FY2021 (-38.9%).
- Quarterly Price to Sales has ranged from 0.59 in Q2 2024 to 34.05 in Q3 2021 over the past five years.
- On a year-over-year basis, Price to Sales rose in six of the last eight quarters, with growth averaging 123.7%.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 465.9% in Q2 2025, against a decline of 95.7% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 2.21 (Q1 2026), 1.97 (Q4 2025) and 2.61 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Spero Therapeutics | 65.71 Mn | -130.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.73 |
| Mar 31, 2026 | 2.21 |
| Dec 31, 2025 | 1.97 |
| Sep 30, 2025 | 2.61 |
| Jun 30, 2025 | 3.35 |
| Mar 31, 2025 | 0.90 |
| Dec 31, 2024 | 1.17 |
| Sep 30, 2024 | 0.68 |
| Jun 30, 2024 | 0.59 |
| Mar 31, 2024 | 0.83 |
| Dec 31, 2023 | 0.75 |
| Sep 30, 2023 | 0.83 |
| Jun 30, 2023 | 1.41 |
| Mar 31, 2023 | 1.42 |
| Dec 31, 2022 | 1.22 |
| Sep 30, 2022 | 9.73 |
| Jun 30, 2022 | 2.63 |
| Mar 31, 2022 | 21.88 |
| Dec 31, 2021 | 28.41 |
| Sep 30, 2021 | 34.05 |
API Access
Spero Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();